[Federal Register Volume 85, Number 59 (Thursday, March 26, 2020)]
[Notices]
[Page 17088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06280]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2020-N-0001]
Preparation for International Cooperation on Cosmetics Regulation
14th Annual Meeting; Public Meeting; Cancellation
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of cancellation of public meeting.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
cancellation of following public meeting entitled ``International
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR-14
Meeting.'' The purpose of the public meeting was to invite public input
on various topics pertaining to the regulation of cosmetics.
DATES: The public meeting was to be held on April 14, 2020, from 2 p.m.
to 4 p.m.
ADDRESSES: The public meeting was to be held at the Food and Drug
Administration, Center for Food Safety and Applied Nutrition, 5001
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.
FOR FURTHER INFORMATION CONTACT: Deborah Smegal, Office of Cosmetics
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-100),
College Park, MD 20740, 240-402-1818, [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
FDA, like other government agencies, is taking the necessary steps
to ensure the Agency is prepared to continue our vital public health
mission in the event that our day-to-day operations are impacted by the
COVID-19 public health emergency. Therefore, we are canceling or
postponing all non-essential meetings through the month of April. We
will reassess on an ongoing basis for future months.
Accordingly, the FDA public meeting entitled, ``International
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR--14
Meeting'' announced in the Federal Register of March 3, 2020 (85 FR
12569), is canceled. Additionally, we will be closing the docket to
public comments, since the purpose of the docket was to obtain
information for the FDA public meeting and to help FDA prepare for the
ICCR-14 meeting. Thus, because we are canceling the FDA public meeting,
public comments are no longer necessary.
As of March 20, 2020, the status of the ICCR-14 meeting itself
remains to be determined.
Please contact Deborah Smegal in FDA's Office of Cosmetics and
Colors (See FOR FURTHER INFORMATION CONTACT) with questions.
Dated: March 20, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-06280 Filed 3-25-20; 8:45 am]
BILLING CODE 4164-01-P